TSHR and Graves ophthalmopathy: Researchers have reported that different microbiomes in mice can lead to different presentations of GD and Graves’ ophthalmopathy after injection with a human thyroid-stimulating hormone receptor (hTSHR) eukaryotic expression plasmid (48).